Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

GPT, an Artificial intelligence copilot that guides scientists through designing and troubleshooting CRISPR gene-editing experiments. Trained on 11 years of expert data, it accelerates experiment ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

CRISPR Therapeutics (CRSP) has been making waves lately, especially after announcing promising early clinical data for its ...

A study using CRISPR restored brain connectivity and made the brain more resilient to seizures, which are often seen in a ...

By upregulating the expression of the lone functioning copy of SCN2A, scientists addressed deficient brain signaling and reduced seizures.

CRISPR Therapeutics (SRSP) stock gains as the company gets a new Overweight rating from J.P. Morgan thanks to its therapeutic ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...